← Eichor
Study identifier: NCT05553873 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study.

Condition: Myeloproliferative Disease · Inflammatory Markers  ·  Sponsor: University of Milano Bicocca

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

This study aims to observe inflammatory biomarkers and their trend over the history of the disease in patients suffering from MPN Ph negative; it also wants to identify any correlations between the aforementioned biomarkers and disease outcomes, considering first of all the occurrence of thrombo-haemorrhagic events and the evolution in the accelerated / blast phase of the disease, shedding light on new tools that can potentially guarantee a prompt and better risk stratification

This description comes directly from the study's public registry record.

Talk to the study team

Elena Maria Elli  ·  0392339859  ·  elena.elli@libero.it

Benedetta Valeri  ·  benedettavalerihsg@gmail.com

Always discuss trial participation with your own doctor first.

Locations (11)

Azienda Ospedaliera Universitaria Consorziale PoliclinicoBari, ItalyRecruiting
Policlinico Sant'Orsola MalpighiBologna, ItalyRecruiting
ASST Spedali Civili di BresciaBrescia, ItalyRecruiting
Policlinico Vittorio EmanueleCatania, ItalyRecruiting
Ospedale Universitario Federico IINaples, ItalyRecruiting
Policlinico Umberto I, Università La SapienzaRoma, ItalyRecruiting
Azienda Ospedaliera Universitaria Città della Salute e delle ScienzaTorino, ItalyRecruiting
Ospedale San Luigi di Orbassano - Ospedale MaurizianoTorino, ItalyRecruiting
Azienda Ospedaliera Universitaria Friuli CentraleUdine, ItalyRecruiting
Azienda Ospedaliera Universitaria IntegrataVerona, ItalyRecruiting
Ospedale BelcolleViterbo, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05553873